• Microfluidics News Admin

[Conference]Rapid antibiotic susceptibility test: Commercialization of life saving MEMS devices


Abstract:

For the timely treatment of patients with infections in bloodstream and cerebrospinal fluid, a rapid antimicrobial susceptibility test (AST) is urgently needed. This paper describe a direct and rapid antimicrobial susceptibility testing (dRAST) system, which can determine the antimicrobial susceptibility of bacteria from a positive blood culture bottle (PBCB) in six hours that conventionally taking more than 30–50 hours. Design consideration, clinical verification, commercialization, and application of dRAST system to tuberculosis are reviewed.

Published in: Micro Electro Mechanical Systems (MEMS), 2017 IEEE 30th International Conference on

Date of Conference: 22-26 Jan. 2017

Date Added to IEEE Xplore: 28 February 2017

DOI: 10.1109/MEMSYS.2017.7863349

Hyun Yong Jeong

Seoul National University, Seoul, REPUBLIC OF Korea

Eun-Geun Kim

Quantamatrix Inc., Seoul, REPUBLIC OF Korea

Sangkwon Han

Quantamatrix Inc., Seoul, REPUBLIC OF Korea

Gi Yoon Lee

Seoul National University, Seoul, REPUBLIC OF Korea

Shinhoon Han

Quantamatrix Inc., Seoul, REPUBLIC OF Korea

Bonghwan Jin

Quantamatrix Inc., Seoul, REPUBLIC OF Korea

Taegeun Lim

Seoul National University, Seoul, REPUBLIC OF Korea

Hee Chan Kim

Seoul National University Hospital, Seoul, REPUBLIC OF Korea

Taek Soo Kim

Seoul National University Hospital, Seoul, REPUBLIC OF Korea

Dongyoung Kim

Seoul National University, Seoul, REPUBLIC OF Korea

Sunghoon Kwon

Seoul National University, Seoul, REPUBLIC OF Korea

Link: http://ieeexplore.ieee.org/abstract/document/7863349/

#susceptibility #infectiousdisease #Biologicalapplication #MEMS

Recent Posts

See All

© 2017 by "Microfluidics News".